@catalent.com
Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
PNG
About
Description
Catalent Pharma is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. Founded in 2007, the company is headquartered in Somerset, New Jersey, United States. Catalent Pharma's primary focus is on providing cutting-edge solutions for the pharmaceutical industry.
Their main products and services include drug delivery technologies, formulation development, clinical supply services, commercial manufacturing, packaging, and supply chain services. They also offer specialized capabilities in areas such as gene therapy, cell therapy, and oral solid dose development. On a global scale, Catalent Pharma operates through multiple facilities and has a significant presence in North America, Europe, Asia Pacific, and Latin America.
The company has a strong network of subsidiaries, joint ventures, and partnerships. Notable subsidiaries include Catalent Biologics, Catalent Cell & Gene Therapy, Catalent Micron Technologies, and Catalent Applied Drug Delivery Institute. They have also established collaborations with leading pharmaceutical companies, research institutions, and academic centers worldwide.
In terms of market position, Catalent Pharma is considered one of the top providers in the pharmaceutical industry. They have a diverse customer base, including multinational pharmaceutical companies, small and mid-sized enterprises, and virtual companies. The company's global sales reach billions of dollars each year, establishing themselves as a key player in the market.
Catalent Pharma has a history of achieving significant milestones and continuous innovation. Some notable achievements include the acquisition of Juniper Pharmaceuticals in 2018, expanding their formulation development and clinical supply capabilities. They have also made advancements in their biologics portfolio, particularly in the area of gene therapies.
Currently, Catalent Pharma is a thriving company that continues to expand its capabilities and global footprint. They remain committed to helping pharmaceutical and biotech companies bring innovative treatments to patients worldwide. The latest updates and key information about the company can be found on their official website or through reliable news sources
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories